Table 1 Risk of poor clinical outcome in obese patients with COVID-19 infection
From: Obesity and COVID-19: what makes obese host so vulnerable?
Reference | No. of Patients | BMI (Kg/m2) | Risk of critical diseaseHR/OR (95% CI) | Risk of DeathHR/OR (95% CI) |
|---|---|---|---|---|
Rottoli et al. (2020) [35] | 482 | ≥ 30 | 2.32 (1.31–4.09) | N/A |
≥ 35 | N/A | 12.1 (3.25–45.1) | ||
Giacomelli et al. (2020) [55] | 233 | ≥ 30 | 8.26 (1.41–48.29) | 3.04 (1.42–6.49) |
Klang et al. (2020) [56] | 3406 | ≥ 40 | N/A | 5.1 (2.3–11.1) |
Docherty et al. (2020) [50] | 20,133 | > 30 | N/A | 1.33 (1.19–1.51) |
Caussy et al. (2020) | 340 | > 30 | 1·89 (1·33–2·53) | NA |
Simonnet et al. (2020) [46] | 124 | ≥ 35 | 7.36 (1.63–33.14) | NA |
30–35 | 3.45 (0.83–14.31) | |||
25–30 | 1.69 (0.52–5.48) | |||
Lighter J et al. (2020) [38] | 725 | 30–34 | 1.8 (1.2–2.7) | NA |
≥ 35 | 3.6 (2.5–5.3) | NA | ||
Palaiodimos et al. (2020) [57] | 200 | ≥ 35 | NA | 3.78 (1.45–9.83) |
Cai et al. (2020) [51] | 383 | ≥ 28 | 3.4 (1.40–2.86) | NA |
Petrilli et al. (2020) [49] | 1999 | ≥ 40 | 2.45 (1.78 to 3.36) | NA |
30–39 | 1.8 (1.47 to 2.2) | |||
25–29.9 | 1.3 (1.07 to 1.57 | |||
Hamer et al. (2020) [58] | 760 | > 30 | 2.05 (1.68, 2.49) | NA |
Zhang et.al (2020) [41] | 340 | ≥ 28 | NA | 1.354 (1.075–1.704) |
Kalligeros et al. (2020) [48] | 103 | ≥ 35 | 5.39 (1.13–25.64) | NA |
Pettit et al. 2020 [59] | 238 | > 30 | NA | 1.7 (1.1–2.8) |